WGS
GeneDx Holdings Corp.$66.73+0.56 (+0.85%)Prev Close$66.17·MCap$1.99B·P/E—·Vol186.5K·Yield—
▲
Buys (12M)
1
$13.46M
▼
Sells (12M)
20
$18.81M
◆
Net Activity
Net Seller
$5.35M
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at GeneDx Holdings Corp. (WGS) has been mixed between buying and selling, with 1 insider purchase totaling $13.46M and 20 insider sales totaling $18.81M. The most recent insider transaction was by Stueland Katherine (director, officer: CHIEF EXECUTIVE OFFICER), who sold $2.96M worth of shares on Mar 30, 2026. GeneDx Holdings Corp. operates in the Healthcare sector, within the Medical - Healthcare Information Services industry, with a market cap of $1.99B.
WGS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | Stueland Katherine | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 46,933 | $63.17 | $2.96M | 125,218-27% |
| Mar 30, 2026 | Feeley Kevin | officer: CHIEF FINANCIAL OFFICER | Sell | 8,818 | $63.17 | $557.1K | 40,913 |
| Mar 17, 2026 | Feeley Kevin | officer: CHIEF FINANCIAL OFFICER | Sell | 5,706 | $76.80 | $438.2K | 30,470 |
| Mar 17, 2026 | Stueland Katherine | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 17,179 | $76.80 | $1.32M | 68,448 |
| Mar 11, 2026 | Feeley Kevin | officer: CHIEF FINANCIAL OFFICER | Sell | 1,280 | $86.75 | $111.0K | 21,842 |
| Mar 5, 2026 | Feeley Kevin | officer: CHIEF FINANCIAL OFFICER | Sell | 6,187 | $78.61 | $486.4K | 23,437 |
| Mar 5, 2026 | Meister Keith A. | director, 10 percent owner: | Buy | 169,521 | $79.40 | $13.46M0.6% OS | 3,228,150 |
| Mar 5, 2026 | Stueland Katherine | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 25,459 | $78.61 | $2.00M | 58,281-30% |
| Feb 6, 2026 | Dechairo Bryan | officer: Chief Operating Officer | Sell | 5,861 | $85.60 | $501.7K | 5,182-53% |
| Feb 3, 2026 | Dechairo Bryan | officer: Chief Operating Officer | Sell | 3,413 | $99.53 | $339.7K | 9,281-27% |
| Feb 2, 2026 | Feeley Kevin | officer: CHIEF FINANCIAL OFFICER | Sell | 317 | $93.99 | $29.8K | 9,170 |
| Feb 2, 2026 | Stueland Katherine | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 1,653 | $94.00 | $155.4K | 16,458 |
| Feb 1, 2026 | Dechairo Bryan | Chief Operating Officer | Sell | 3,413 | $99.53 | $339.7K | 0 |
| Jan 29, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 1,653 | $94.00 | $155.4K | 0 |
| Dec 16, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 3,855 | $143.87 | $554.6K | 0 |
| Nov 24, 2025 | RUCH JOSHUA | Director | Sell | 38,000 | $160.37 | $6.09M | 0 |
| Oct 29, 2025 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 2,158 | $136.54 | $294.7K | 0 |
| Sep 16, 2025 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 10,501 | $121.47 | $1.28M | 0 |
| Sep 1, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 378 | $125.81 | $47.6K | 0 |
| Jul 1, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 9,657 | $90.94 | $878.2K | 0 |
| Jun 9, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 3,639 | $72.55 | $264.0K | 0 |
| Apr 9, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 15,516 | $92.18 | $1.43M | 0 |
| Mar 28, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 8,746 | $95.61 | $836.2K | 16,324-35% |
| Mar 28, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 46,551 | $95.62 | $4.45M | 50,064-48% |
| Mar 17, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 4,151 | $96.07 | $398.8K | 8,492-33% |
| Mar 17, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 11,637 | $96.04 | $1.12M | 14,865-44% |
| Mar 11, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 922 | $94.72 | $87.3K | 5,446 |
| Mar 11, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 2,731 | $94.73 | $258.7K | 7,752-26% |
| Mar 4, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 261 | $103.94 | $27.1K | 3,906 |
| Jan 31, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 275 | $78.48 | $21.6K | 2,950 |
| Jan 31, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 1,657 | $78.48 | $130.0K | 3,937-30% |
| Jan 10, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 35,506 | $93.82 | $3.33M | 13,905-72% |
| Jan 10, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 51,420 | $94.48 | $4.86M | 29,340-64% |
| Jan 6, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 1,430 | $76.04 | $108.7K | 27,881 |
| Jan 6, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 18,006 | $78.18 | $1.41M | 68,492 |
| Dec 18, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 3,728 | $76.75 | $286.1K | 28,200 |
| Dec 18, 2024 | Stueland Katherine | Chief Executive Officer | Sell | 10,501 | $76.75 | $806.0K | 71,146 |
| Dec 11, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 1,137 | $76.37 | $86.8K | 24,731 |
| Dec 11, 2024 | Stueland Katherine | Chief Executive Officer | Sell | 3,661 | $76.37 | $279.6K | 62,897 |
| Dec 3, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 263 | $78.39 | $20.6K | 23,406 |
| Nov 25, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 22,000 | $74.81 | $1.65M | 44,751-33% |
| Nov 21, 2024 | Ryan Jason | Sell | 47,000 | $70.57 | $3.32M | 41,048-53% | |
| Nov 19, 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Sell | 147,141 | $70.64 | $10.39M0.5% OS | 2,846,474 | |
| Nov 19, 2024 | Stueland Katherine | Chief Executive Officer | Sell | 45,415 | $70.41 | $3.20M | 99,929-31% |
| Nov 4, 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Sell | 865,800 | $75.00 | $64.94M3.0% OS | 2,866,833 | |
| Oct 31, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 274 | $66.60 | $18.2K | 44,951 |
| Oct 31, 2024 | Stueland Katherine | Chief Executive Officer | Sell | 2,154 | $66.60 | $143.5K | 105,426 |
| Sep 18, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 2,635 | $37.59 | $99.0K | 44,472 |
| Sep 18, 2024 | Stueland Katherine | Chief Executive Officer | Sell | 10,501 | $37.59 | $394.7K | 103,706 |
| Sep 11, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 895 | $33.33 | $29.8K | 39,910 |
Showing 1–50 of 179
1 / 4
WGS Insider Buying Activity
The following table shows recent insider purchases of GeneDx Holdings Corp. (WGS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Meister Keith A. | director, 10 percent owner: | Buy | 169,521 | $79.40 | $13.46M0.6% OS | 3,228,150 |
WGS Insider Selling Activity
The following table shows recent insider sales of GeneDx Holdings Corp. (WGS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | Stueland Katherine | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 46,933 | $63.17 | $2.96M | 125,218-27% |
| Mar 30, 2026 | Feeley Kevin | officer: CHIEF FINANCIAL OFFICER | Sell | 8,818 | $63.17 | $557.1K | 40,913 |
| Mar 17, 2026 | Feeley Kevin | officer: CHIEF FINANCIAL OFFICER | Sell | 5,706 | $76.80 | $438.2K | 30,470 |
| Mar 17, 2026 | Stueland Katherine | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 17,179 | $76.80 | $1.32M | 68,448 |
| Mar 11, 2026 | Feeley Kevin | officer: CHIEF FINANCIAL OFFICER | Sell | 1,280 | $86.75 | $111.0K | 21,842 |
| Mar 5, 2026 | Feeley Kevin | officer: CHIEF FINANCIAL OFFICER | Sell | 6,187 | $78.61 | $486.4K | 23,437 |
| Mar 5, 2026 | Stueland Katherine | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 25,459 | $78.61 | $2.00M | 58,281-30% |
| Feb 6, 2026 | Dechairo Bryan | officer: Chief Operating Officer | Sell | 5,861 | $85.60 | $501.7K | 5,182-53% |
| Feb 3, 2026 | Dechairo Bryan | officer: Chief Operating Officer | Sell | 3,413 | $99.53 | $339.7K | 9,281-27% |
| Feb 2, 2026 | Feeley Kevin | officer: CHIEF FINANCIAL OFFICER | Sell | 317 | $93.99 | $29.8K | 9,170 |
| Feb 2, 2026 | Stueland Katherine | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 1,653 | $94.00 | $155.4K | 16,458 |
| Feb 1, 2026 | Dechairo Bryan | Chief Operating Officer | Sell | 3,413 | $99.53 | $339.7K | 0 |
| Jan 29, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 1,653 | $94.00 | $155.4K | 0 |
| Dec 16, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 3,855 | $143.87 | $554.6K | 0 |
| Nov 24, 2025 | RUCH JOSHUA | Director | Sell | 38,000 | $160.37 | $6.09M | 0 |
| Oct 29, 2025 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 2,158 | $136.54 | $294.7K | 0 |
| Sep 16, 2025 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 10,501 | $121.47 | $1.28M | 0 |
| Sep 1, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 378 | $125.81 | $47.6K | 0 |
| Jul 1, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 9,657 | $90.94 | $878.2K | 0 |
| Jun 9, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 3,639 | $72.55 | $264.0K | 0 |
| Apr 9, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 15,516 | $92.18 | $1.43M | 0 |
| Mar 28, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 8,746 | $95.61 | $836.2K | 16,324-35% |
| Mar 28, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 46,551 | $95.62 | $4.45M | 50,064-48% |
| Mar 17, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 4,151 | $96.07 | $398.8K | 8,492-33% |
| Mar 17, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 11,637 | $96.04 | $1.12M | 14,865-44% |
| Mar 11, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 922 | $94.72 | $87.3K | 5,446 |
| Mar 11, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 2,731 | $94.73 | $258.7K | 7,752-26% |
| Mar 4, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 261 | $103.94 | $27.1K | 3,906 |
| Jan 31, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 275 | $78.48 | $21.6K | 2,950 |
| Jan 31, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 1,657 | $78.48 | $130.0K | 3,937-30% |
| Jan 10, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 35,506 | $93.82 | $3.33M | 13,905-72% |
| Jan 10, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 51,420 | $94.48 | $4.86M | 29,340-64% |
| Jan 6, 2025 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 1,430 | $76.04 | $108.7K | 27,881 |
| Jan 6, 2025 | Stueland Katherine | Chief Executive Officer | Sell | 18,006 | $78.18 | $1.41M | 68,492 |
| Dec 18, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 3,728 | $76.75 | $286.1K | 28,200 |
| Dec 18, 2024 | Stueland Katherine | Chief Executive Officer | Sell | 10,501 | $76.75 | $806.0K | 71,146 |
| Dec 11, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 1,137 | $76.37 | $86.8K | 24,731 |
| Dec 11, 2024 | Stueland Katherine | Chief Executive Officer | Sell | 3,661 | $76.37 | $279.6K | 62,897 |
| Dec 3, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 263 | $78.39 | $20.6K | 23,406 |
| Nov 25, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 22,000 | $74.81 | $1.65M | 44,751-33% |
| Nov 21, 2024 | Ryan Jason | Sell | 47,000 | $70.57 | $3.32M | 41,048-53% | |
| Nov 19, 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Sell | 147,141 | $70.64 | $10.39M0.5% OS | 2,846,474 | |
| Nov 19, 2024 | Stueland Katherine | Chief Executive Officer | Sell | 45,415 | $70.41 | $3.20M | 99,929-31% |
| Nov 4, 2024 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Sell | 865,800 | $75.00 | $64.94M3.0% OS | 2,866,833 | |
| Oct 31, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 274 | $66.60 | $18.2K | 44,951 |
| Oct 31, 2024 | Stueland Katherine | Chief Executive Officer | Sell | 2,154 | $66.60 | $143.5K | 105,426 |
| Sep 18, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 2,635 | $37.59 | $99.0K | 44,472 |
| Sep 18, 2024 | Stueland Katherine | Chief Executive Officer | Sell | 10,501 | $37.59 | $394.7K | 103,706 |
| Sep 11, 2024 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 895 | $33.33 | $29.8K | 39,910 |
WGS Insiders
Stueland Katherine
director, officer: CHIEF EXECUTIVE OFFICER
Bought $100.0KSold $27.26M
36 tradesLast: Mar 30, 2026
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
10% Owner
Bought $35.00MSold $75.33M
4 tradesLast: Nov 19, 2024
Blackstone Tactical Opportunities Associates III - NQ L.P.
10% Owner
Bought $10.00M
1 tradesLast: May 3, 2022
Similar Stocks to WGS
GEHC
GE HealthCare Technologies Inc.
$68.93-2.16%
$33.83B
VEEV
Veeva Systems Inc.
$158.86-0.98%
$27.78B
TEM
Tempus AI, Inc.
$51.24-2.70%
$9.68B
BTSG
BrightSpring Health Services, Inc. Common Stock
$47.96-1.31%
$9.13B
DOCS
Doximity, Inc.
$24.78+0.53%
$4.51B
HNGE
Hinge Health, Inc.
$45.01-0.44%
$3.49B
PRVA
Privia Health Group, Inc.
$24.59+0.76%
$2.96B
TXG
10x Genomics, Inc.
$21.56-3.23%
$2.82B